1. Home
  2. CNTB vs HIT Comparison

CNTB vs HIT Comparison

Compare CNTB & HIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTB
  • HIT
  • Stock Information
  • Founded
  • CNTB 2012
  • HIT 1964
  • Country
  • CNTB United States
  • HIT United States
  • Employees
  • CNTB N/A
  • HIT N/A
  • Industry
  • CNTB Biotechnology: Pharmaceutical Preparations
  • HIT Specialty Insurers
  • Sector
  • CNTB Health Care
  • HIT Finance
  • Exchange
  • CNTB Nasdaq
  • HIT Nasdaq
  • Market Cap
  • CNTB 44.2M
  • HIT 37.2M
  • IPO Year
  • CNTB 2021
  • HIT 2024
  • Fundamental
  • Price
  • CNTB $1.00
  • HIT $0.80
  • Analyst Decision
  • CNTB Strong Buy
  • HIT Strong Buy
  • Analyst Count
  • CNTB 2
  • HIT 1
  • Target Price
  • CNTB $7.50
  • HIT $2.50
  • AVG Volume (30 Days)
  • CNTB 93.6K
  • HIT 261.7K
  • Earning Date
  • CNTB 05-15-2025
  • HIT 08-15-2025
  • Dividend Yield
  • CNTB N/A
  • HIT N/A
  • EPS Growth
  • CNTB N/A
  • HIT N/A
  • EPS
  • CNTB N/A
  • HIT 0.02
  • Revenue
  • CNTB $26,033,000.00
  • HIT $22,380,959.00
  • Revenue This Year
  • CNTB N/A
  • HIT $58.79
  • Revenue Next Year
  • CNTB N/A
  • HIT N/A
  • P/E Ratio
  • CNTB N/A
  • HIT $45.15
  • Revenue Growth
  • CNTB N/A
  • HIT 11.24
  • 52 Week Low
  • CNTB $0.51
  • HIT $0.51
  • 52 Week High
  • CNTB $1.73
  • HIT $7.59
  • Technical
  • Relative Strength Index (RSI)
  • CNTB 59.56
  • HIT N/A
  • Support Level
  • CNTB $0.91
  • HIT N/A
  • Resistance Level
  • CNTB $1.12
  • HIT N/A
  • Average True Range (ATR)
  • CNTB 0.08
  • HIT 0.00
  • MACD
  • CNTB 0.01
  • HIT 0.00
  • Stochastic Oscillator
  • CNTB 59.26
  • HIT 0.00

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

About HIT Health In Tech Inc. Class A Common Stock

Health In Tech Inc is an insurance technology platform company. It offers a marketplace that processes in the healthcare industry through vertical integration, process simplification, and automation. The group removed friction and complexities, it streamlined the underwriting, sales, and service process for insurance companies, licensed brokers, and TPAs.

Share on Social Networks: